Omeros (OMER) Change in Receivables (2010 - 2026)
Omeros (OMER) posted Change in Receivables of $1.1 million for Q1 2026, down 72.19% sequentially from $4.0 million in Q4 2025, and up 268.17% YoY from $302845.1 in Q1 2025.
Analysis
Omeros (OMER) Change in Receivables (2010 - 2026) Analysis & Trends
Omeros has reported Change in Receivables for 17 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Change in Receivables rose 268.17% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 975.62% YoY) and the FY2025 annual result came in at $3.2 million, up 990.2% from the prior year.
- Change in Receivables fell to $1.1 million in Q1 2026 per OMER's latest filing, from $4.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $199.4 million in Q4 2022 and troughed at -$203.2 million in Q1 2023.
- A 5-year average of -$1.5 million and a median of -$454000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables jumped 4583.27% in 2022, then sank 827.8% in 2023.
- Over 5 years, Change in Receivables stood at $199.4 million in 2022, then sank by 99.39% to $1.2 million in 2023, then increased by 17.65% to $1.4 million in 2024, then jumped by 179.76% to $4.0 million in 2025, then plunged by 72.19% to $1.1 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $1.1 million, $4.0 million, and $632000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 9.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.27 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | 438,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | -4.31 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | -203.19 Mn |
| Dec 31, 2022 | 199.37 Mn |
| Sep 30, 2022 | -625,000.00 |
| Jun 30, 2022 | -1.78 Mn |
| Mar 31, 2022 | -21.90 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 2.06 Mn |